Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study - PubMed (original) (raw)
Comparative Study
. 2002 Nov;11(11):1375-81.
Affiliations
- PMID: 12433714
Comparative Study
Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study
Merethe Kumle et al. Cancer Epidemiol Biomarkers Prev. 2002 Nov.
Abstract
Current use of oral contraceptives (OCs) has been reported to increase breast cancer risk slightly. In 1991/1992, a prospective cohort study specifically designed to examine the role of hormonal contraceptives in relation to breast cancer was conducted in Norway and Sweden. This study was entitled Women's Lifestyle and Health. Of 196,000 invited women aged 30-49 years, 106,844 women answered a 4-page questionnaire. Altogether, 103,027 women providing information on contraceptive use were included in the analysis presented here, and 1,008 primary invasive breast cancers were diagnosed throughout 1999 (end of follow-up). Proportional hazard regression was used to calculate relative risks (RRs) with adjustment for age and other possible confounders. An increased breast cancer risk was observed among women who were current/recent users of OCs of any type at the start of follow-up [RR, 1.6; 96% confidence interval (CI), 1.2-2.1]. Current/recent use (i.e., use in the year preceding cohort enrolment) of combined OCs (RR, 1.5; 95% CI, 1.0-2.0) and progestin-only pills (RR, 1.6; 95% CI, 1.0-2.4) entailed similar levels of increased risk. An increased risk of borderline significance was found among short-term (i.e., less than 13 months) users before age 20 years (RR, 1.3; 95% CI, 1.0-1.7) and before first full-term pregnancy (RR, 1.4; 95% CI, 1.0-1.8). Long-term users of OCs were at a higher risk of breast cancer than never users (test for trend, P = 0.005). Current/recent use of OCs is associated with an increased breast cancer risk. Use of combined OCs and progestin-only pills seem to increase the risk at the same level.
Similar articles
- Breast cancer among young U.S. women in relation to oral contraceptive use.
White E, Malone KE, Weiss NS, Daling JR. White E, et al. J Natl Cancer Inst. 1994 Apr 6;86(7):505-14. doi: 10.1093/jnci/86.7.505. J Natl Cancer Inst. 1994. PMID: 8133534 - Exogenous progestins and breast cancer.
Stanford JL, Thomas DB. Stanford JL, et al. Epidemiol Rev. 1993;15(1):98-107. doi: 10.1093/oxfordjournals.epirev.a036120. Epidemiol Rev. 1993. PMID: 8405216 Review. - Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway.
Meirik O, Lund E, Adami HO, Bergström R, Christoffersen T, Bergsjö P. Meirik O, et al. Lancet. 1986 Sep 20;2(8508):650-4. doi: 10.1016/s0140-6736(86)90166-2. Lancet. 1986. PMID: 2876135 - Oral contraceptives and breast cancer.
Brinton LA, Hoover R, Szklo M, Fraumeni JF Jr. Brinton LA, et al. Int J Epidemiol. 1982 Dec;11(4):316-22. doi: 10.1093/ije/11.4.316. Int J Epidemiol. 1982. PMID: 7152784 - Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
Carr BR, Ory H. Carr BR, et al. Contraception. 1997 May;55(5):267-72. doi: 10.1016/s0010-7824(97)00029-2. Contraception. 1997. PMID: 9220222 Review.
Cited by
- Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies.
Zhang X, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Gapstur SM, Giles GG, Giovannucci E, Goodman G, Hankinson SE, Helzlsouer KJ, Horn-Ross PL, Inoue M, Jung S, Khudyakov P, Larsson SC, Lof M, McCullough ML, Miller AB, Neuhouser ML, Palmer JR, Park Y, Robien K, Rohan TE, Ross JA, Schouten LJ, Shikany JM, Tsugane S, Visvanathan K, Weiderpass E, Wolk A, Willett WC, Zhang SM, Ziegler RG, Smith-Warner SA. Zhang X, et al. Am J Clin Nutr. 2012 Mar;95(3):713-25. doi: 10.3945/ajcn.111.014415. Epub 2012 Jan 25. Am J Clin Nutr. 2012. PMID: 22277553 Free PMC article. - Mediterranean dietary pattern and risk of breast cancer.
Couto E, Sandin S, Löf M, Ursin G, Adami HO, Weiderpass E. Couto E, et al. PLoS One. 2013;8(2):e55374. doi: 10.1371/journal.pone.0055374. Epub 2013 Feb 4. PLoS One. 2013. PMID: 23390532 Free PMC article. - Dietary fat and breast cancer risk in the Swedish women's lifestyle and health cohort.
Löf M, Sandin S, Lagiou P, Hilakivi-Clarke L, Trichopoulos D, Adami HO, Weiderpass E. Löf M, et al. Br J Cancer. 2007 Dec 3;97(11):1570-6. doi: 10.1038/sj.bjc.6604033. Epub 2007 Oct 16. Br J Cancer. 2007. PMID: 17940510 Free PMC article. - Hormonal contraceptive use and breast cancer in Thai women.
Poosari A, Promthet S, Kamsa-ard S, Suwanrungruang K, Longkul J, Wiangnon S. Poosari A, et al. J Epidemiol. 2014;24(3):216-20. doi: 10.2188/jea.je20130121. Epub 2014 Mar 7. J Epidemiol. 2014. PMID: 24614914 Free PMC article. - Effects of Endocrine Interventions Targeting ERα or PR on Breast Cancer Risk in the General Population and Carriers of BRCA1/2 Pathogenic Variants.
Huber D, Hatzipanagiotou M, Schüler-Toprak S, Ortmann O, Treeck O. Huber D, et al. Int J Mol Sci. 2024 May 28;25(11):5894. doi: 10.3390/ijms25115894. Int J Mol Sci. 2024. PMID: 38892081 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical